Supernus Pharmaceuticals, Inc. recalls Trokendi XR
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed dissolution specifications.
- Products
-
- Trokendi XR
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 11304 bottles
- About this recall
- Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.